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Late Onset of von Recklinghausens Disease
Abstract. Neuroﬁbromatosis is an autosomal dominant
genetic disorder, although it may occur as a spontaneous
mutation; clinically it is characterized by typical peripheral
nerve tumours (Neuroﬁbromas) and cafe au lait spots; they
are more frequent over the trunk and legs. In this particular
case study a patient with neuroﬁbromatosis is described,
who, besides the characteristic cafe au tait spots at birth,
has developed, late and rapidly, lesions of neuroﬁ-
bromatous origin in the submammary region, right hip and
bilaterally in the areolar region.
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Given the extreme variability of its clinical signs,
neuroﬁbromatosis is a diﬃcult disorder to classify.
Neuroﬁbromatosis 1, the more common type, is a
dominant autosomal genetic disease characterized by
high penetration with variable expressivity. It has an
incidence of approximately 1 in 3,000 live births [1].
The responsible gene is located on the long arm of
chromosome 17, which normally encodes a protein
that acts as a tumor suppressor. The spontaneous
mutation is thought to contribute to 50% of neuro-
ﬁbromatosis cases [2]. Neuroﬁbromatosis is charac-
terized clinically by skin lesions, benign tumors of
peripheral nerves, and sometimes tumors and mal-
formations of the central nervous system [3]. The
most common signs of neuroﬁbromatosis are pig-
mented cafe` au lait spots with regular margins, ﬂat
and variable in size, on the skin over the trunk,
buttocks, and legs. Although the spots usually appear
at birth or by the age of 1 year, the number of spots
may increase in number during early infancy and in
size during puberty [4]. Neuroﬁbromas are very
common and characterized by a noticeable prolifer-
ation of ﬁbroblasts of neural mast cells and Schaumm
cells. These are located along the skin nerves and
mucosae as well as on the trunk of somatic and vis-
ceral nerves. Related osseous alterations such as ki-
phoscoliosis, pseudarthrosis, and erosive lesions of
the long bones are frequent. Eye conditions such as
hamartomas of the iris and Lish nodules are less
common [5,6].
Case Report
A 27-year-old woman presented with multiple skin
neoformations over the left and right mammary and
submammary regions and the right hip. The family
history for genetically transmitted diseases was
negative back to the third generation. Medical
examination showed multiple cafe` au lait spots on
the trunk and in the leg regions, which according to
the patient, appeared in her infancy, but in smaller
numbers and sizes. Multiple pedunculate neofor-
mations were present on the right and left areolar
regions as well as a large pedunculate neoformation
that extended from the submammary region to the
right hip. The neoformation was indolent, soft, and
hyperpigmented (Fig. 1). According to the patient,
these signs appeared at the age of 24 years on hy-
perpigmented skin spots. With regard to cranial
nerves, no defect was detected. The total body
computed tomography (CT) examination showed no
lesion or malformation.
The patient underwent routine lab investigations.
The patient then had surgery for complete removal of
the submammary lesion, and subsequently underwent
a histologic test, which conﬁrmed the neuroﬁbroma
diagnosis. A total excision was performed for the
right and left areolar lesions, with successive recon-
struction of tissue layers by means of local ﬂaps.
Thanks to the histologic test as well as clinical and
instrumental ﬁndings, neuroﬁbromatosis type 1 was
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diagnosed according to the diagnostic criteria of
National Health Institute Consensus Conference
(NHICC) (Table 1). With the patients consent, a
follow-up program with the following periodic
examinations was begun:
 Clinical examination with accurate control of the
whole cutaneous surface in order to detect new
lesions
 Ophthalmologic, neurologic, and psychiatric
evaluations
 CT or magnetic resonance imaging (MRI)
examinations and total body scintigraphy
 Electroencephalogram and evoked visual
potentials
 Mammography.
These examinations have yielded negative results
since the surgery. This case is interesting because of
the late onset of the cutaneous neoformations, which
as a rule occur by the second decade of life. Neuro-
ﬁbromatosis is a very rare genetic pathology, and
given the dramatic variability of clinical signs, may be
diﬃcult to diagnose, especially in patients with a
negative family history and in cases with typical
lesions that appear late. As a matter of fact, in the
reported case, the ﬁrst diagnosis of the pathology was
made when the patient was 27 years old.
Discussion
In 1988, the HNICC established the criteria for a
diagnosis of neuroﬁbromatosis 1. For a diagnosis to
be made, at least two of the signs in Table 1 must be
present. A correct diagnosis requires careful clinical
and instrumental evaluation to detect the presence of
characteristic signs and to exclude the presence of
related brain tumors.
The role of plastic surgery is fundamental to a
correct evaluation and excision of cutaneous lesions.
In cases similar to the reported case, total excision of
neoformations with subsequent plastic surgery not
only guarantees good aesthetic and functional results,
but also protects the patient from rare but possible
sarcomatous transformation of cutaneous lesions
whose incidence varies between 2% and 16% [7].
Accurate pre- and postsurgery mammographic
screening is indispensable for patients with this
pathology. As a matter of fact, researchers describe
cases in which lesions are early malignant neuroﬁ-
bromas [5–8].
Moreover, case studies have been described in
which neuroﬁbromatosis is associated with mammary
cancer, such as the invasive duct cancer [1,4,8]. In such
cases, the presence of large neoformations may impair
the detection of nodules by means of palpation. It is
advisable also to monitor the patient after surgery to
Fig. 1. A 27-year old woman
with neuroﬁbromatosis type 1.
Note the multiple peduncolated
neuroﬁbromas arising from un-
der the mammary region on the
right side and on both nipple–
areolar complexes. (A) Lateral
projection. (B) Frontal projec-
tion.
Table 1. National Health Institute criteria for the diagnosis of Neuroﬁbromatosis Type 1
1. Six or more cafe´ au lait spots with a maximal diameter of 5 mm in prepubertal individuals and larger than 15 mm in
postpubertal individuals
2. Two or more neuroﬁbromas of any type, or one plexiform neuroﬁbroma
3. Inguinal or axillary freckling
4. Optic glioma
5. Two or more Lisch nodules
6. Distinctive osseous lesion such as sphenoid wing dysplasia or cortical thinning of long bones
7. A ﬁrst-degree relative who meets the neuroﬁbromatosis type 1 diagnostic criteria
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avoid the onset of complications associated with the
disease that may make the prognosis worse.
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